OR5B10P

Across TCGA pan-cancer cohorts, OR5B10P RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated OR5B10P data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher OR5B10P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR5B10P expression acts as an unfavorable survival marker, although some lineages such as BLCA show a favorable association.

STAD, THYM, and LGG are the cancer types where OR5B10P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	IV	0.111	0.433	.002	69	view →
THYM	DFS	Tertile	II,III,IV	0.145	0.873	<.001	36	view →
LGG	DFS	Tertile	All	0.597	0.761	.001	30	view →
SKCM	DFS	Tertile	III,IV	0.145	0.618	.001	27	view →
KIRC	DFS	Tertile	III,IV	0.255	0.483	.011	24	view →
PCPG	DFS	Tertile	All	0.161	0.819	.004	18	view →
BLCA	DFS	Tertile	IV	1.000	0.197	.036	12	view →
UCEC	OS	Tertile	All	0.785	0.928	.029	12	view →
GBM	DFS	Tertile	All	0.151	0.272	.012	9	view →
PRAD	DFS	Tertile	All	0.553	0.935	.040	6	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

OR5B10P–STAD (OS)

Open the STAD breakdown →